首页 | 本学科首页   官方微博 | 高级检索  
     


A Phase II Study of Preradiotherapy Chemotherapy Followed by Hyperfractionated Radiotherapy for Newly Diagnosed High-Risk Medulloblastoma/Primitive Neuroectodermal Tumor: A Report From the Children's Oncology Group (CCG 9931)
Authors:Jeffrey Allen  Bernadine Donahue  Minesh Mehta  Douglas C. Miller  Lucy B. Rorke  Regina Jakacki  Patricia Robertson  Richard Sposto  Emi Holmes  Gilbert Vezina  Karin Muraszko  Diane Puccetti  Michael Prados  Ka-Wah Chan
Affiliation: Departments of Pediatrics and Pathology, New York University Medical Center, New York, NY; Department of Radiation Oncology, Maimonides Medical Center, Brooklyn, NY; Department of Radiation Oncology, Children''s Hospital, Madison, WI;§ Department of Pathology, Children''s Hospital of Philadelphia, Philadelphia, PA; Department of Pediatric Oncology, Children''s Hospital, Pittsburgh, PA; Department of Neurology, C.S. Mott Children''s Hospital, Ann Arbor, MI;# Departments of Preventive Medicine and Pediatrics (Children''s Hospital Los Angeles), Keck School of Medicine at the University of Southern California, Los Angeles, CA;∗∗ Children''s Oncology Group Operations Office, Arcadia, CA;†† Department of Radiology, National Children''s Medical Center, Washington, DC;‡‡ Department of Neurosurgery, University of Michigan, Ann Arbor, MI;§§ University of Wisconsin Children''s Hospital, Madison, WI;‖‖ Department of Neurosurgery, University of California, San Francisco, CA;¶¶ Methodist Children''s Hospital of South Texas, San Antonio, TX
Abstract:
Keywords:PNET   Medulloblastoma (high risk)   Hyperfractionated radiotherapy   Preradiation chemotherapy
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号